Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ROSEN RECOGNIZED INVESTOR COUNSEL Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action

February 14, 2025
Pharmaceutical company GSK plc (LON:GSK) has recently faced a securities class action that may have significant implications for its investors. ROSEN RECOGNIZED INVESTOR COUNSEL, a leading law firm specializing in such cases, is encouraging GSK plc investors to secure legal representation before an upcoming important deadline. The class action alleges that GSK plc made false and misleading statements regarding the effectiveness and safety of certain drugs, resulting in significant financial losses for investors. Investors are advised to seek the advice of professionals such as Stocks Prognosis to make informed decisions about the future movements of GSK plc's stocks.
If you want to leave a comment, then you need Login or Register





Other data for GSK

Related data

GSKJuly 17, 2025QuantWave Successfully Predicts GSK PLC Stock Movement, Achieving 7.53% Profit  ~2 min.

QuantWave, the automated forecasting platform, has once again proven its accuracy with the successful prediction of the price movement of GSK PLC stock....


GSKJuly 17, 2025QuantWave Hits Bullseye with GSK PLC Forecast, Achieving 7.53% Profit  ~2 min.

On May 27, 2025, QuantWave, the automated forecasting platform, issued a short signal for GSK PLC with a price target of 36.07 $. The stock was trading at 39....


GSKJune 12, 2025QuantWave Achieves 14.92% Profit Target Forecast for GSK PLC  ~1 min.

QuantWave, the automated forecasting platform, successfully reached a price target forecast for GSK PLC, yielding a profit of 14.92%....


GSKJune 12, 2025QuantWave Successfully Achieves 10.55% Profit Target Forecast for GSK PLC  ~2 min.

QuantWave, the automated forecasting platform, has recently hit a milestone with its accurate prediction for the stock of GSK PLC....


GSKJune 12, 2025QuantWave Hits Bullseye with GSK PLC Forecast, Generating 9.06% Profit  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has once again demonstrated its accuracy with an impressive 9.06% profit on the stock of GSK PLC....


GSKJune 12, 2025QuantWave Forecast Hits the Mark: GSK PLC Stock Reaches Price Target with 9.53% Profit  ~2 min.

On March 21, 2025, QuantWave, the automated forecasting platform, issued a long signal for GSK PLC stock when it was trading at $38.37. Fast forward to June 12, 2025, the predicted target of $42....


GSKJune 12, 2025QuantWave Hits Price Target Forecast for GSK PLC with 7.32% Profit  ~2 min.

On March 7, 2025, QuantWave, an automated forecasting platform, successfully forecasted a price target for the stock GSK PLC. The signal indicated a long position when the stock was trading at 39.16 $....


GSKJune 12, 2025QuantWave Successfully Predicts GSK PLC Stock Price, Generating 11.84% Profit  ~1 min.

On March 4th, 2025, QuantWave, the automated forecasting platform, issued a long signal for GSK PLC stock at a price of $37.58....


GSKJune 12, 2025QuantWave Forecasts Success: GSK PLC Hits Price Target with 8.84% Profit  ~1 min.

On March 14, 2025, QuantWave, an automated forecasting platform, issued a long signal for the stock of GSK PLC at a price of 38.61 $. Fast forward to June 12, 2025, the target price of 42....


GSKJune 12, 2025QuantWave Achieves 8.81% Profit Target Forecast for GSK PLC Stock  ~1 min.

QuantWave, the automated forecasting platform, successfully reached its price target forecast for GSK PLC stock, with a profit margin of 8.81%....


REGNJanuary 25, 2025Deadline Alert: Regeneron Pharmaceuticals Inc. REGN  ~1 min.

Regeneron Pharmaceuticals Inc. (REGN) is facing an important deadline, as investors who have lost money are being urged to contact Glancy Prongay Murray LLP about a securities fraud lawsuit....


REGNJanuary 12, 2025Regeneron Pharmaceuticals Faces Shareholder Class Action Lawsuit  ~1 min.

Regeneron Pharmaceuticals, Inc., a leading biotechnology company, is currently facing a shareholder class action lawsuit....


REGNJanuary 9, 2025Regeneron Pharmaceuticals REGN Faces Securities Class Action After Losing 9 Billion Value Following Q3 2024 Earnings Report Hagens Berman  ~1 min.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is facing a securities class action after losing $9 billion in value following its Q3 2024 earnings report....


REGNJanuary 22, 2025Regeneron Pharmaceuticals REGN Faces Securities Class Action After Losing 9 Billion Value Following Q3 2024 Earnings Report  ~1 min.

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is facing a securities class action after suffering a massive value loss of 9 billion following their Q3 2024 earnings report....


REGNFebruary 2, 2025Regeneron Pharmaceuticals Inc. Faces Class Action Lawsuit  ~2 min.

Regeneron Pharmaceuticals Inc. (REGN) is currently facing a class action lawsuit filed by investors....